D. Iskender Et Al. , "TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME," 13th International Symposium on Myelodysplastic Syndromes (MDS) , vol.39, Washington, Kiribati, 2015
Iskender, D. Et Al. 2015. TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. 13th International Symposium on Myelodysplastic Syndromes (MDS) , (Washington, Kiribati).
Iskender, D., Gurkan, E., & Baslamisli, F., (2015). TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME . 13th International Symposium on Myelodysplastic Syndromes (MDS), Washington, Kiribati
Iskender, D., E. Gurkan, And F. Baslamisli. "TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME," 13th International Symposium on Myelodysplastic Syndromes (MDS), Washington, Kiribati, 2015
Iskender, D. Et Al. "TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME." 13th International Symposium on Myelodysplastic Syndromes (MDS) , Washington, Kiribati, 2015
Iskender, D. Gurkan, E. And Baslamisli, F. (2015) . "TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME." 13th International Symposium on Myelodysplastic Syndromes (MDS) , Washington, Kiribati.
@conferencepaper{conferencepaper, author={D. Iskender Et Al. }, title={TET2 MUTATIONAL STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME}, congress name={13th International Symposium on Myelodysplastic Syndromes (MDS)}, city={Washington}, country={Kiribati}, year={2015}}